(Total Views: 497)
Posted On: 10/19/2021 2:35:59 PM
Post# of 62
$HGEN News Article - Humanigen Announces Late-Breaking Presentation at the CHEST Annual Meeting Highlighting C-Reactive Protein as a Biomarker for Identifying Patients Most Likely to Benefit from treatment with Lenzilumab https://marketwirenews.com/news-releases/huma...31528.html
(0)
(0)
My Twitter: WhyteStocks
